Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
on an ODX RNS day...…….
Thus it ever was.
Don't know why it always seems to print my posts twice.
They're not THAT good!!!
Very succinctly put bitl.
In one fell swoop Wyndrum has demolished the Diagnostic Division of AVCT.
Moderna vaccines will render the world disease free ergo no need for diagnosis ergo Good bye AVCT diagnostic Division.
What on earth will the NHS do?
Maybe change its name to the National Hamster Service or something?
Very succinctly put bitl.
In one fell swoop Wyndrum has demolished the Diagnostic Division of AVCT.
Moderna vaccines will render the world disease free ergo no need for diagnosis ergo Good bye AVCT diagnostic Division.
What on earth will the NHS do?
Maybe change its name to the National Hamster Service or something?
I bet some looked at the title to this post and thought they would prefer a bucket of cold sick!
Because we instinctively feel that "realism" is the province of the pessimist.
Honestly I sometimes look at this BB at the end of the day and am convinced most of us hail from Yorkshire.
We love a good moan and why not!!!!
We also love a good slanging match with each other (so that the BB begins to resemble the Monty Python Office where you go if you want to have a pointless argument).
Funny thing is 95% of us (scientifically proven) actually agree on five things.
1. Whether or not AVCT may have made better decisions re the LFT they have also had incredibly bad luck with it (fault of third parties)
2 AVA 6000 works
3 The share price is pants
4 It is very likely to vastly VASTLY improve over the next year.
5. Its hard to be patient AAAAAAAAAAAARGH!!!!!!!!!!!!!!!!!
I bet some looked at the title to this post and thought they would prefer a bucket of cold sick!
Because we instinctively feel that "realism" is the province of the pessimist.
Honestly I sometimes look at this BB at the end of the day and am convinced most of us hail from Yorkshire.
We love a good moan and why not!!!!
We also love a good slanging match with each other (so that the BB begins to resemble the Monty Python Office where you go if you want to have a pointless argument).
Funny thing is 95% of us (scientifically proven) actually agree on five things.
1. Whether or not AVCT may have made better decisions re the LFT they have also had incredibly bad luck with it (fault of third parties)
2 AVA 6000 works
3 The share price is pants
4 It is very likely to vastly VASTLY improve over the next year.
5. Its hard to be patient AAAAAAAAAAAARGH!!!!!!!!!!!!!!!!!
unless they are "pausing"
You too PL75.
Agree also with you Zoom.
Among the more helpful posts on the SNG site was the most ticked up one about looking after your mental health.
Be kind to others but most of all be kind to yourself.
Could apply to some here?
We all need to discern our own strategies. Each to their own but may I say a particularly unattractive one is the strategy of inculcating fear.
I suspect most of the Long termers will be holding regardless of what the price does in anticipation of summer and beyond.
Those of us with that strategy will be concentrating on the glorious fundamentals here!
Eric Sprott (billionaire investor) secret of share success. Buy early sit tight. Don't look at day to day share fluctuations.
I wonder if affiDX picks up Deltacron?
The market is generally being spooked a bit because of Putins antics.
There have been some poisonous posters on here over the Weekend and some who should know better.
There is no excuse for the venom being directed at a man whose Company has over 14/15 years acquired the rights to affimers and precision both of which are gamechangers in the world of medicine and who at last has a chance to see these developed. Acquiring these platforms is amazing enough for a mini biotech.
Covid provided the chance to fast track (yes fast track) them.
You could accuse him of naivity for thinking we could be the next Roche (although nice to see how much he is convinced by the science)
You could also accuse him of naivity for trusting the Government.
You could also be cheesed off if you think he puts scientific integrity before short term shareholder value.
We don't any of us know the full LFT story and there will be good business reasons why we don't. We do know (or we should if we trust the company) that it is not over by a long chalk.
It is unarguable that we are currently grossly undervalued.
GLA all decent investors.
I always like to be civil to folks (although you probably don't want a meaningful dialogue) so welcome to our board.
May not do any harm to correct a few missapprehensions
Its not binary
MC is not inflated anymore cos of covid. Shares are worth 155p ex covid according to our well respected world class broker (not one of your diddy ones you will be used to)
Covid play hasn't failed here
Re commercialisation licenses are a possibility this summer which will constitute a huge inflexion point according to the CEO. Stage payments re other joint ventures also to be expected.
And thats just Aldebarans Post.
And the rest of the trolls are not as erudite as he!
Ha ha cider2go.
However I think that AS has not been either rampy or waffly since Stiffel came on board.
I reckon what comes out of the company or indeed AS mouth now we can put a high level of trust in.
Agreed PL75.
IMO AS has been trying to play down the significance of the LFT in comparison to the therapeutics since well before Omicron.
I suspect he is as frustrated as anyone that AIM still seems to think we are a Covid company.
But there is a little niggle in my mind that the LFT is not going away.
affIDX FOR Covid 19 merited a page of its own in the recent investors presentation.
The company say they are still on it.
The scientific officer for WHO this morning told us to expect new variants.
Not saying we'll neccesarily get an announcement in the next couple of months but surely better to have that prospect in our back pocket than not?
Sorry Mr Ripley.
Nice to see most still here.
Frustrated yes
Unbelieving at the SP and others power to manipulate yes
Face Palming at AIM Markets company valuations yes
Digging in for a possibly attrirional 2-3 months (until FOMO starts) yes
But still here
And the reason we are still here.
Because deep down we still believe that AVCT science has a WOW factor like no other.
And that eventually the blood sweat tears and insults will all be worth it!
I would suggest that peeps not in yet who plan to get in before summer play it very carefully.
Don't underestimate the power of FOMO.
Especially if the media gets its paws on this.
Its quite simple.
Chemo without symptoms.
Look at lesser shes such as HE1 (sorry Wyndrum)
They are not drilling for more Helium till after the summer but still FOMO has taken them from 6 to 11.
We used to have a respected analyst on here by the name of Mapp.
"AIM is a game" she would say (and if we are a football for the next week or two it makes no difference to me!)
I suggest that those of us who intend to hold until after mid summer at least can be reasonably confident of a multibag from here.
If the traders (decent and indecent) wish to try for smaller beans in the meantime that's their business.
You're not the only one Pal.
I'm here for the duration.
Like I said "Come what May"
Funnily enough although I know what you mean about sitting on a big paper loss not being easy I find that its much easier for me now that I have made an irrevocable decision not to sell come what may.
I will either be rich or poor after a year or so
I will not be in between.
I believe I will be rich.
But now the decision is made I am at peace about it.
Robbo
I just want to add my best wishes as you look to the future and say I've enjoyed your input.
I have taken the alternative decision to remain (literally) all in to the end whether that end is bitter or glorious.
All the best
As AgentB points out they are now searching for a new "affimer or antibody" to pair with the existing affimer.
This won't neccesarily be a long process.
What they don't know yet is how the regulator may view the amended test or how protracted any following regulatory process might be.
They'll update the market when they do.
One other "benefit" of the pause is that they have the chance to work to get the "cost of goods" out of the product as well.
I would imagine that replacing the antibody with an affimer would have significant "cost of goods" advantages but would an "all affimer" test encourage the regulator to want to take another look?